| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2007-Breast, Brain Mets, Sacituzumab Govitecan | 1 | Y | 1 Sacituzumab Govitecan | 44 | 25 | 3 | 1 | 0 | 0 | 0 | 06/08/2021 | 184 | 57 |
| 25 | 3 | 1 | 0 | 0 | 0 | |||||||||
| S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 264 | 261 | 182 | 112 | 32 | 4 | 11/27/2023 | 346 | 118 | |
| 264 | 261 | 182 | 112 | 32 | 4 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 43 | 43 | 34 | 23 | 5 | 1 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 42 | 42 | 32 | 20 | 6 | 0 | ||||||||
| 85 | 85 | 66 | 43 | 11 | 1 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 191 | 183 | 107 | 60 | 16 | 2 | 09/15/2023 | 306 | 130 | |
| 2 Carbo + Docetaxel + Pembro | 194 | 182 | 115 | 67 | 19 | 0 | ||||||||
| 385 | 365 | 222 | 127 | 35 | 2 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 48 | 9 | 4 | 2 | 1 | 1 | 03/11/2021 | 426 | 206 | |
| 48 | 9 | 4 | 2 | 1 | 1 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 14 | 11 | 6 | 4 | 2 | 1 | 08/24/2023 | 350 | 179 | ||
| 14 | 11 | 6 | 4 | 2 | 1 | |||||||||
| MA39-BREAST, Node-Pos, Reg RT vs No Reg RT | 1 | E | Total Registrations | 43 | 21 | 13 | 6 | 2 | 0 | 10/18/2019 | 381 | 148 | ||
| 43 | 21 | 13 | 6 | 2 | 0 | |||||||||
| 2 | E | Total Registrations | 42 | 20 | 13 | 6 | 2 | 0 | 10/18/2019 | |||||
| 42 | 20 | 13 | 6 | 2 | 0 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | 142 | 55 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | EA1211-Breast, HER2+, NeoAdj Therapy | 1 | E | Total Registrations | 5 | 5 | 4 | 3 | 3 | 0 | 05/06/2024 | 5 | 5 | |
| 5 | 5 | 4 | 3 | 3 | 0 | |||||||||
| NRGBR007-Breast, Stg I, De-Escalation of Breast RT | 1 | E | Total Registrations | 12 | 6 | 3 | 0 | 0 | 0 | 06/01/2022 | 395 | 174 | ||
| 12 | 6 | 3 | 0 | 0 | 0 | |||||||||
| 2 | E | Total Registrations | 12 | 6 | 4 | 0 | 0 | 0 | 06/01/2022 | |||||
| 12 | 6 | 4 | 0 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 8 | 8 | 5 | 2 | 2 | 1 | 01/31/2024 | 436 | 180 | ||
| 8 | 8 | 5 | 2 | 2 | 1 | |||||||||
| 2 | E | Total Registrations | 8 | 8 | 5 | 2 | 2 | 1 | 01/31/2024 | |||||
| 8 | 8 | 5 | 2 | 2 | 1 | |||||||||